Internal Medicine, Cardiovascular Disease · Glendale, CA
NPI
1255314514
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
660 W Broadway
Glendale, CA, 91204
Phone (818) 243-9600
Medicare paid, 2024
$428K
8,266 services
Medicare patients, 2024
1,198
Average age 76
Drug cost, 2024
$3.8M
12,967 prescriptions
Company payments, 2025
$1,261
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Onkarjit S Marwah was code 93000 (electrocardiogram), 1,332 times for 643 patients. In total Onkarjit S Marwah billed 8,266 services in 80 codes, and Medicare paid $428K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 1,332 | 643 | $12.01 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 1,139 | 318 | $64.91 | $74K |
| 99213 Office E&M - Established | Office | 900 | 518 | $73.66 | $66K |
| 99214 Office E&M - Established | Office | 429 | 337 | $109.34 | $47K |
| 93306 Echocardiography (TTE/TEE) | Office | 368 | 338 | $174.46 | $64K |
| 99458 E&M - Miscellaneous | Office | 242 | 49 | $31.98 | $7,739 |
| 99223 Hospital E&M - Initial | Facility | 234 | 196 | $142.42 | $33K |
| 99454 E&M - Miscellaneous | Office | 218 | 54 | $42.32 | $9,226 |
| 99457 E&M - Miscellaneous | Office | 190 | 55 | $39.67 | $7,537 |
| 93010 Electrocardiogram | Facility | 183 | 152 | $6.56 | $1,201 |
| 85025 Blood Count | Office | 179 | 166 | $7.61 | $1,362 |
| 80053 Clinical Chemistry | Office | 177 | 164 | $10.35 | $1,832 |
| 83036 Blood Count | Office | 168 | 157 | $9.52 | $1,599 |
| 80061 Clinical Chemistry | Office | 167 | 156 | $13.12 | $2,191 |
| 82306 Clinical Chemistry | Office | 160 | 153 | $29.01 | $4,642 |
By year: 2022 $448K for 5,618 services; 2023 $456K for 7,343 services; 2024 $428K for 8,266 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 179 | 166 | $7.61 | $1,362 |
| 80053 Clinical Chemistry | 177 | 164 | $10.35 | $1,832 |
| 83036 Blood Count | 168 | 157 | $9.52 | $1,599 |
| 80061 Clinical Chemistry | 167 | 156 | $13.12 | $2,191 |
| 82306 Clinical Chemistry | 160 | 153 | $29.01 | $4,642 |
| 83735 Clinical Chemistry | 159 | 152 | $6.57 | $1,045 |
| 84443 Clinical Chemistry | 159 | 152 | $16.46 | $2,617 |
| 86141 Clinical Chemistry | 157 | 151 | $12.69 | $1,992 |
| 36415 Venipuncture Blood Collection | 135 | 124 | $8.65 | $1,168 |
| 82607 Clinical Chemistry | 92 | 90 | $14.78 | $1,360 |
Medicare prescription drug claims, 2024
In 2024, the drug Onkarjit S Marwah prescribed most often to Medicare patients was Amlodipine Besylate, with 1,045 prescriptions and refills. In total Onkarjit S Marwah wrote 12,967 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,045 | 1,698 | 219 | $2,510 |
| Clopidogrel Clopidogrel Bisulfate | 902 | 1,294 | 140 | $4,236 |
| Metoprolol Succinate Generic | 679 | 943 | 110 | $4,872 |
| Furosemide Generic | 606 | 843 | 109 | $1,336 |
| Hydralazine Hcl Generic | 596 | 733 | 97 | $4,308 |
| Atorvastatin Calcium Generic | 559 | 903 | 107 | $2,740 |
| Eliquis Apixaban | 507 | 621 | 88 | $350K |
| Nifedipine Er Nifedipine | 475 | 718 | 86 | $6,723 |
| Carvedilol Generic | 463 | 718 | 78 | $2,022 |
| Losartan Potassium Generic | 424 | 703 | 88 | $1,877 |
| Amiodarone Hcl Generic | 398 | 516 | 70 | $4,664 |
| Rosuvastatin Calcium Generic | 384 | 561 | 73 | $2,324 |
| Entresto Sacubitril/Valsartan | 325 | 467 | 59 | $300K |
| Potassium Chloride Generic | 277 | 382 | 53 | $3,348 |
| Metolazone Generic | 256 | 345 | 45 | $5,510 |
Brand drugs: - claims; generic drugs: 10,737 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Onkarjit S Marwah $1,261 ($1,261 in general payments such as food, travel and fees) from 12 companies. The largest payer was Merck Sharp & Dohme LLC with $250.
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC MRK | 3 | $250 |
| Actelion Pharmaceuticals US, Inc. JNJ | 8 | $241 |
| Medtronic, Inc. MDT | 2 | $169 |
| Abbott Laboratories ABT | 2 | $153 |
| Shockwave Medical, Inc JNJ | 2 | $129 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $118 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $53.86 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $50.54 |
| Abiomed JNJ | 1 | $36.83 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $26.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.